Skip to main content

Table 1 Patients’ demographic and perioperative data

From: Impeding factors of early rehabilitation postoperatively after rheumatoid toe arthroplasty: a single-center retrospective cohort study

Variables Possible group Impossible group P value
N 191 109  
Age (years) 63.7 (10.6) 62.1 (10.1) 0.20
Male/female 14/177 4/105 0.20
Height (cm) 155.2 (7.2) 156.1 (7.2) 0.30
Weight (kg) 51.3 (9.0) 51.3 (8.6) 0.99
Medications    
 Daily prednisolone medication, n (%) 81 (42.4%) 36 (33.0) 0.11
 Daily prednisolone dose (mg) 0 [0–2.75] 0 [0–2.25] 0.22
 Number of DMARDs taken by patients 1 [1–2] 1 [1–2] 0.37
Duration of surgery (min) 102.2 (37.4) 109.6 (34.1) 0.09
 Number of operated toes    
Duration of anesthesia (min) 154.4 (42.3) 162.3 (39.5) 0.11
Intraoperative fluid volume (ml) 918.4 (306.6) 1000.5 (329.5) 0.03
Blood loss (g) 2.3 (5.3) 3.9 (8.0) 0.03
Anesthesia methods    
 General anesthesia, n (%) 160 (83.8%) 89 (81.7%) 0.64
 Regional anesthesia, n (%) 105 (55.0%) 47 (43.1%) 0.05
 Epidural anesthesia, n (%) 28 (14.7%) 21 (19.3%) 0.30
 Spinal anesthesia, n (%) 31 (16.3%) 20 (18.3%) 0.64
 Peripheral nerve block, n (%) 58 (30.1%) 13 (11.9%) < 0.001
Intraoperative fentanyl dose (μg) 250 [0–400] 300 [50–400] 0.14
Postoperative fentanyl use, n (%) 75 (39.3%) 57 (52.3%) 0.03
Incidence of PONV before rehabilitation, n (%) 42 (22.0%) 47 (43.1%) < 0.001
Number of rescue analgesics administered before rehabilitation 1 [0–1] 1 [0–2] 0.01
Days from surgery to discharge 14.7 (0.4) 14.7 (0.6) 0.94
  1. Data are presented as mean (SD), median [interquartile range], or number (%)
  2. DMARDs disease-modifying anti-rheumatic drugs, PONV postoperative nausea and vomiting